Get the Stockscreener App
293.87
1.52%
4.41
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cme Group Inc stock is traded at $293.87, with a volume of 2.14M.
It is up +1.52% in the last 24 hours and up +7.86% over the past month.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
See More
Previous Close:
$289.46
Open:
$291.68
24h Volume:
2.14M
Relative Volume:
1.08
Market Cap:
$105.67B
Revenue:
$6.76B
Net Income/Loss:
$4.26B
P/E Ratio:
25.08
EPS:
11.717
Net Cash Flow:
$4.33B
1W Performance:
+4.74%
1M Performance:
+7.86%
6M Performance:
-0.79%
1Y Performance:
+11.95%
1-Day Range:
$289.50
$293.97
1-Week Range:
$276.38
$293.97
52-Week Range:
$218.31
$329.16
Cme Group Inc Stock (CME) Company Profile
Name
Cme Group Inc
Sector
Phone
(312) 930-1000
Address
20 S. WACKER DR., CHICAGO, IL
Compare CME vs SPGI, ICE, MCO, NDAQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CME
Cme Group Inc
|
293.87 | 105.67B | 6.76B | 4.26B | 4.33B | 11.72 |
SPGI
S P Global Inc
|
429.64 | 126.66B | 15.73B | 5.15B | 5.56B | 15.81 |
ICE
Intercontinental Exchange Inc
|
161.56 | 90.70B | 12.93B | 3.99B | 4.24B | 6.8684 |
MCO
Moodys Corp
|
485.07 | 84.00B | 7.87B | 2.50B | 2.75B | 13.95 |
NDAQ
Nasdaq Inc
|
93.97 | 52.53B | 8.27B | 1.91B | 2.00B | 3.3193 |
Cme Group Inc Stock (CME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-02-26 | Initiated | Wells Fargo | Overweight |
| Aug-19-26 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-18-26 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Jun-11-26 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Jun-05-26 | Downgrade | Erste Group | Buy → Hold |
| Apr-08-26 | Resumed | Keefe Bruyette | Mkt Perform |
| Mar-04-26 | Downgrade | Argus | Buy → Hold |
| Jan-14-26 | Upgrade | TD Cowen | Hold → Buy |
| Oct-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-25-25 | Upgrade | Citigroup | Neutral → Buy |
| Jul-24-25 | Downgrade | UBS | Buy → Neutral |
| Apr-08-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-10-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-06-25 | Downgrade | Citigroup | Buy → Neutral |
| Oct-08-24 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Sep-27-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-26-24 | Initiated | TD Cowen | Hold |
| Sep-03-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-21-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-08-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-03-24 | Downgrade | Goldman | Neutral → Sell |
| Sep-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-28-23 | Initiated | Barclays | Overweight |
| Jan-05-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-12-22 | Initiated | Citigroup | Buy |
| Oct-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-17-22 | Initiated | Rosenblatt | Sell |
| Aug-15-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-10-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
| May-25-22 | Upgrade | Oppenheimer | Perform → Outperform |
| May-16-22 | Downgrade | Argus | Buy → Hold |
| Feb-15-22 | Initiated | Credit Suisse | Neutral |
| Feb-10-22 | Reiterated | BofA Securities | Underperform |
| Feb-10-22 | Reiterated | Citigroup | Buy |
| Feb-10-22 | Reiterated | Compass Point | Neutral |
| Feb-10-22 | Reiterated | Deutsche Bank | Hold |
| Feb-10-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jan-20-22 | Upgrade | Rosenblatt | Sell → Neutral |
| Dec-16-21 | Initiated | BofA Securities | Underperform |
| Sep-14-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jun-25-21 | Resumed | Credit Suisse | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-30-21 | Downgrade | Argus | Buy → Hold |
| Mar-24-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-01-21 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Feb-25-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-15-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-08-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-23-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Sep-11-20 | Initiated | Loop Capital | Sell |
| Apr-14-20 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-26-20 | Upgrade | UBS | Neutral → Buy |
| Jan-10-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-16-19 | Initiated | Credit Suisse | Neutral |
| Sep-19-19 | Downgrade | Berenberg | Buy → Hold |
| Sep-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-18-19 | Downgrade | Rosenblatt | Neutral → Sell |
| Feb-15-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-11-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Dec-04-18 | Resumed | Barclays | Overweight |
| Nov-28-18 | Initiated | Atlantic Equities | Neutral |
| Nov-28-18 | Downgrade | UBS | Buy → Neutral |
| Nov-20-18 | Upgrade | Berenberg | Hold → Buy |
| Nov-20-18 | Resumed | Citigroup | Buy |
| Nov-05-18 | Resumed | BofA/Merrill | Buy |
| Jul-10-18 | Initiated | Compass Point | Neutral |
| Apr-10-18 | Initiated | Bernstein | Outperform |
View All
Cme Group Inc Stock (CME) Latest News
Wells Fargo lifts target for CME Group stock to USD 315.00 - ad-hoc-news.de
Zacks Industry Outlook Highlights S&P Global, CME, Intercontinental Exchange, Nasdaq and Cboe Global Markets - Zacks Investment Research
Zacks Industry Outlook Highlights S&P Global, CME, Intercontinental Exchange, Nasdaq and Cboe Global Markets - TradingView
There's a 35% Chance That the Fed Hikes Rates at Least 4 Times by September 2027, Which Can Decimate the AI-Driven Bull Market - The Motley Fool
CME Group Inc. Cl A stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
5 Securities & Exchanges Stocks to Watch Amid Industry Headwinds - Zacks Investment Research
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Zacks Investment Research
CME Group (CME) Stock Fair Value Edges Higher As Analysts Weigh Growth And Competition - Yahoo Finance
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Zacks Investment Research
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
News Flash: Trumpflation Is Expected to Ramp Up the Fed's Rate-Hiking Cycle in 2027 - The Motley Fool
Tesla FuturesContract Specs - CME Group
NYSE owner plans futures for livestock in challenge to CME - Crain's Chicago Business
Will CBOE Maintain Strong Earnings Growth Beyond Market Volatility? - Zacks Investment Research
NYSE owner plans futures for livestock in a bid to challenge CME Group - National Hog Farmer
CME Group (Nasdaq:CME)Stock Analysis - Simply Wall Street
Can CME Group Sustain Trading Momentum Amid Easing Volatility? - TradingView
Can CME Group Sustain Trading Momentum Amid Easing Volatility? - Zacks Investment Research
Can CME Group Sustain Trading Momentum Amid Easing Volatility? - Yahoo Finance
Deutsche Bank Adjusts Price Target on CME Group to $277 From $270 - www.marketscreener.com
CME Group: I Missed The Best Entry (NASDAQ:CME) - Seeking Alpha
The 10-Year Treasury Yield Is Near a 24-Year High. History Says Stock Investors Should Do This 1 Thing. - The Motley Fool
Strong 10-Year note auction lifts yields. - CME Group
CME Group Inc. Cl A stock outperforms competitors on strong trading day - MarketWatch
Baseball may get its first stats-based trading contracts Oct. 12, pending regulatory review. - Stock Titan
CME Group launched loan futures and CME Group stock costs EUR 243.45 - AD HOC NEWS
CME Group (CME) Sees 22% Surge in International Trading Volume D - GuruFocus
CME Group (CME) Posts Strong Q3 Volume Growth, Boosting Dividend Sustainability Outlook - GuruFocus
CME Group Logs 22% Jump in Q3 International Average Daily Volume - marketscreener.com
CME Group's international ADV rises 22% in Q3 (CME:NASDAQ) - Seeking Alpha
CME Group's International Average Daily Volume Rises 22% to 9 Million Contracts in Q3 2026 - www.marketscreener.com
CME Group (CME) International ADV Up 22% to 9M in Q3 - TradingView
CME Group's International Average Daily Volume Rises 22% to 9 Million Contracts in Q3 2026 - Yahoo Finance
CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst (NASDAQ:CME) - Seeking Alpha
Can ICE's Exchange Business Sustain Its Growth Momentum? - Zacks Investment Research
Why Investors Need to Take Advantage of These 2 Finance Stocks Now - Zacks Investment Research
Marex announces changes to Group Board - GlobeNewswire Inc.
CME Group (CME) vs. Intercontinental Exchange (ICE): Which Exchange Giant Is the Better Buy? - Yahoo Finance
CME shelves plans for 24/7 oil contract amid industry qualms - Crain's Chicago Business
UBS Adjusts Price Target on CME Group to $270 From $260, Keeps Neutral Rating - marketscreener.com
Cboe Global Secures 25-Year SPX Rights: Can Volume Boost Growth? - Zacks Investment Research
CME Group Plans Futures Contracts for AI Computing Capacity - Yahoo Finance
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research
UBS raises CME Group stock price target to $270 on strong volumes - Investing.com
TD Cowen Adjusts Price Target on CME Group to $300 From $292, Keeps Buy Rating - marketscreener.com
CME Group suspends plan for 24/7 10-barrel crude oil contract (CME:NASDAQ) - Seeking Alpha
EUR/USD - CME Group
Raymond James Adjusts CME Group Price Target to $320 From $330, Maintains Outperform Rating - marketscreener.com
The U.S. Economy Added 29,000 Jobs in September, Far Fewer Than Expected. Here's Why That's Good News for the Stock Market Right Now. - The Motley Fool
Goldman Sachs Adjusts Price Target on CME Group to $254 From $252, Keeps Sell Rating - marketscreener.com
Cme Group Inc Stock (CME) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cme Group Inc Stock (CME) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JONATHAN MARCUS | Officer |
Sep 16 '26 |
Proposed Sale |
273.46 |
388 |
106,102 |
0 |
| Cook Elizabeth A | Director |
Sep 14 '26 |
Sale |
280.11 |
500 |
140,055 |
17,916 |
| ELIZABETH ANNE COOK TRUST | Director |
Sep 14 '26 |
Proposed Sale |
280.11 |
500 |
140,052 |
0 |
| Terrence Duffy | Officer |
Sep 10 '26 |
Proposed Sale |
275.00 |
15,000 |
4,125,000 |
0 |
| DUFFY TERRENCE A | Chairman and CEO |
Sep 10 '26 |
Sale |
274.44 |
15,000 |
4,116,539 |
40,630 |
| SHEPARD WILLIAM R | Director |
Jun 25 '26 |
Buy |
230.57 |
14 |
3,301 |
3,621 |
| SHEPARD WILLIAM R | Director |
Jun 25 '26 |
Buy |
230.57 |
325 |
74,885 |
260,442 |
| Piell Hilda Harris | Sr MD & Chief HR Officer |
May 18 '26 |
Sale |
304.63 |
5,753 |
1,752,536 |
27,702 |
| HILDA PIELL 1998 TR | Officer |
May 18 '26 |
Proposed Sale |
304.63 |
5,753 |
1,752,536 |
0 |
| DUFFY TERRENCE A | Chairman and CEO |
May 15 '26 |
Sale |
298.51 |
35,000 |
10,447,866 |
55,630 |
1.99%
5.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):